OXALIPLATIN Side Effects

6942198-7 | Ileal Perforation, Pyrexia, Rectal Perforation, White Blood Cell Count Increased
on Aug 16, 2010 Male patient from JAPAN , 68 years of age, weighting 105.8 lb, was diagnosed with rectal cancer recurrent and was treated with Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: ileal perforation, pyrexia, rectal perforation, white blood cell count increased. Oxaliplatin dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ).

6942052-0 | Abdominal Pain, Colitis, Diarrhoea
Patient was taking Oxaliplatin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), colitis, diarrhoea on Aug 16, 2010 from GERMANY Additional patient health information: Female patient , 50 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Oxaliplatin dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

6942006-4 | Dehydration, Diarrhoea, Multi-organ Failure
Adverse event was reported on Aug 13, 2010 by a Male patient taking Oxaliplatin (View Usage) (Dosage: ) . Location: GERMANY , 51 years of age, After Oxaliplatin was administered, patient had the following side effects: dehydration, diarrhoea, multi-organ failure. During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), EMBOLEX (View Embolex Review and Embolex Label ). Patient was hospitalized.

6938165-X | Diarrhoea, Electrocardiogram Qt Prolonged, Fatigue, Loss Of Consciousness, Nausea, Ventricular Tachycardia
on Aug 17, 2010 Female patient from GERMANY , 74 years of age, weighting 132.3 lb, was diagnosed with rectal cancer and was treated with Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, electrocardiogram qt prolonged, fatigue, loss of consciousness, nausea (What is nausea?), ventricular tachycardia. Oxaliplatin dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), DOXEPIN HCL (View Doxepin Hcl Review and Doxepin Hcl Label ), FERRO ^SANOL^ (View Ferro ^sanol^ Review and Ferro ^sanol^ Label ), FORADIL (View Foradil Review and Foradil Label ), MERIGEST (1 Df = 2/5 Mg) (View Merigest Review and Merigest Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SOTAHEXAL (View Sotahexal Review and Sotahexal Label ). Patient was hospitalized.


6934940-6 | Laryngospasm, Muscle Spasms, Paraesthesia, Stridor
on Aug 11, 2010 Female patient from UNITED KINGDOM , 74 years of age, weighting 184.7 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Oxaliplatin (View Usage). Patient had the following side effects: laryngospasm, muscle spasms, paraesthesia, stridor. Oxaliplatin dosage: 250 Mg, Unk. During the same period patient was treated with BENDROFLUAZIDE (5 Mg, Qd) (View Bendrofluazide Review and Bendrofluazide Label ), HERBAL EXTRACTS NOS (10 Ml, Bid) (View Herbal Extracts Nos Review and Herbal Extracts Nos Label ), LACTULOSE (10 L, Prn) (View Lactulose Review and Lactulose Label ), RAMIPRIL (2.5 Mg, Bid) (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6931394-0 | Dyspnoea, Femoral Artery Embolism, Peripheral Ischaemia, Urosepsis
Patient was taking Oxaliplatin (View Usage). After Oxaliplatin was administered, patient had the following side effects: dyspnoea, femoral artery embolism, peripheral ischaemia, urosepsis on Aug 12, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 60 years of age, . Oxaliplatin dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ADCAL (View Adcal Review and Adcal Label ). Patient was hospitalized.

6929852-8 | Cachexia, Cholecystitis, Dehydration, Diarrhoea, Fistula, Pneumonia, Pyothorax
Adverse event was reported on Aug 11, 2010 by a Male patient taking Oxaliplatin (View Usage) (Dosage: ) . Location: GERMANY , 39 years of age, Patient experienced the following unwanted or unexpected effects: cachexia, cholecystitis, dehydration, diarrhoea, fistula (What is fistula?), pneumonia (What is pneumonia?), pyothorax. During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), CALCIUM GLUCONATE (Before And After Infusion Of Oxaliplatin) (View Calcium Gluconate Review and Calcium Gluconate Label ), MAGNESIUM SULFATE (Before And After Infusion Of Oxaliplatin) (View Magnesium Sulfate Review and Magnesium Sulfate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), KEVATRIL (View Kevatril Review and Kevatril Label ), CLEMASTINE FUMARATE (View Clemastine Fumarate Review and Clemastine Fumarate Label ). Patient was hospitalized.

6929841-3 | Cachexia, Cholecystitis, Dehydration, Diarrhoea, Fistula, Pneumonia, Pyothorax
on Aug 11, 2010 Male patient from GERMANY , 39 years of age, was treated with Oxaliplatin (View Usage). Patient had the following side effects: cachexia, cholecystitis, dehydration, diarrhoea, fistula (What is fistula?), pneumonia (What is pneumonia?), pyothorax. Oxaliplatin dosage: . During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), CALCIUM GLUCONATE (Before And After Infusion Of Oxaliplatin) (View Calcium Gluconate Review and Calcium Gluconate Label ), MAGNESIUM SULFATE (Before And After Infusion Of Oxaliplatin) (View Magnesium Sulfate Review and Magnesium Sulfate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), KEVATRIL (View Kevatril Review and Kevatril Label ), CLEMASTINE FUMARATE (View Clemastine Fumarate Review and Clemastine Fumarate Label ). Patient was hospitalized.

6929727-4 | Blood Pressure Increased, Leukoencephalopathy, Ovarian Haemorrhage
on Aug 11, 2010 Female patient from JAPAN , 42 years of age, was diagnosed with rectal cancer metastatic and was treated with Oxaliplatin (View Usage). After Oxaliplatin was administered, patient had the following side effects: blood pressure increased, leukoencephalopathy, ovarian haemorrhage. Oxaliplatin dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), AVASTIN (View Avastin Review and Avastin Label ).

6927764-7 | Gastrointestinal Haemorrhage
Patient was taking Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage on Aug 06, 2010 from JAPAN Additional patient health information: Male patient , 61 years of age, was diagnosed with rectal cancer and. Oxaliplatin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ).

6927737-4 | Anaphylactic Shock
Adverse event was reported on Aug 12, 2010 by a Male patient taking Oxaliplatin (View Usage) (Dosage: ) was diagnosed with colon cancer and. Location: JAPAN , 78 years of age, Patient had the following side effects: anaphylactic shock. During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6925335-X | Haemolysis
on Aug 04, 2010 Male patient from BELGIUM , 59 years of age, weighting 200.6 lb, was diagnosed with colon cancer, hypertension and was treated with Oxaliplatin (View Usage). After Oxaliplatin was administered, patient had the following side effects: haemolysis. Oxaliplatin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ), ZESTRIL (View Zestril Review and Zestril Label ).

6925071-X | Demyelinating Polyneuropathy
on Aug 04, 2010 Male patient from GERMANY , 65 years of age, was treated with Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: demyelinating polyneuropathy. Oxaliplatin dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6924453-X | Haemodialysis, Haemolysis, Renal Failure Acute, Thrombocytopenia
Patient was taking Oxaliplatin (View Usage). Patient had the following side effects: haemodialysis, haemolysis, renal failure acute, thrombocytopenia on Jul 27, 2010 from FRANCE Additional patient health information: Male patient , 65 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Oxaliplatin dosage: 470 Mg Total Dose, Intravenous Drip. During the same period patient was treated with FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6923305-9 | Diarrhoea, Electrolyte Imbalance, Nephropathy Toxic
Adverse event was reported on Aug 04, 2010 by a Male patient taking Oxaliplatin (View Usage) (Dosage: ) was diagnosed with gastric cancer and. Location: NETHERLANDS , 75 years of age, After Oxaliplatin was administered, patient had the following side effects: diarrhoea, electrolyte imbalance, nephropathy toxic. During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

6919269-4 | Anaphylactic Shock, Cardio-respiratory Arrest
on Jul 30, 2010 Male patient from JAPAN , 70 years of age, weighting 134.5 lb, was diagnosed with colon cancer and was treated with Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, cardio-respiratory arrest. Oxaliplatin dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ).

6919212-8 | Acute Myocardial Infarction, Angina Unstable, Diarrhoea, Epistaxis, Fatigue, Nausea, Neuropathy Peripheral, Rash, Stomatitis
on Jul 30, 2010 Male patient from JAPAN , 66 years of age, weighting 114.6 lb, was diagnosed with colon cancer metastatic and was treated with Oxaliplatin (View Usage). Patient had the following side effects: acute myocardial infarction, angina unstable, diarrhoea, epistaxis, fatigue, nausea (What is nausea?), neuropathy peripheral, rash (What is rash?), stomatitis. Oxaliplatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), AVASTIN (View Avastin Review and Avastin Label ), RHYTHMY (View Rhythmy Review and Rhythmy Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ). Patient was hospitalized.

6919092-0 | Abdominal Pain Upper, Bile Duct Stenosis, Nephrotic Syndrome
Patient was taking Oxaliplatin (View Usage). After Oxaliplatin was administered, patient had the following side effects: abdominal pain upper, bile duct stenosis, nephrotic syndrome on Jul 30, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with gastric cancer and. Oxaliplatin dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ), ZOFRAN (View Zofran Review and Zofran Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), CARAFATE (View Carafate Review and Carafate Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6917596-8 |
Adverse event was reported on Jul 30, 2010 by a Female patient taking Oxaliplatin (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: IRELAND , 65 years of age, weighting 99.21 lb, . During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), RANTAC (View Rantac Review and Rantac Label ), DEXONA (View Dexona Review and Dexona Label ).

6915070-6 | Biliary Tract Disorder, Blood Bilirubin Increased, Decreased Appetite, Malignant Neoplasm Progression, Mass, Metastatic Gastric Cancer, Pruritus, Tumour Compression, Yellow Skin
on Aug 05, 2010 Male patient from UNITED STATES , weighting 194.4 lb, was diagnosed with gastric cancer and was treated with Oxaliplatin (View Usage). Patient had the following side effects: biliary tract disorder, blood bilirubin increased, decreased appetite, malignant neoplasm progression, mass, metastatic gastric cancer, pruritus, tumour compression, yellow skin. Oxaliplatin dosage: 130mg/m2 D1, 8, 15 Each Cycle Iv. During the same period patient was treated with CETUXIMAB (250 Mg/m2 D1, 8, 15 Each Cycle Iv) (View Cetuximab Review and Cetuximab Label ), XELODA (850 Mg/m2 D1-14 Each Cycle, Bid Po) (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

6913464-6 | Neuropathy Peripheral, Papilloedema
on Jul 28, 2010 Male patient from SWEDEN , 62 years of age, was diagnosed with colon cancer and was treated with Oxaliplatin (View Usage). After Oxaliplatin was administered, patient had the following side effects: neuropathy peripheral, papilloedema. Oxaliplatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), BETAPRED (View Betapred Review and Betapred Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ). Patient was hospitalized.

6913392-6 | Organising Pneumonia
Patient was taking Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: organising pneumonia on Jul 28, 2010 from SPAIN Additional patient health information: Male patient , 82 years of age, weighting 149.9 lb, was diagnosed with colorectal cancer metastatic, hypertension and. Oxaliplatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ). Patient was hospitalized.

6911442-4 | Deafness Neurosensory, Deafness Unilateral, Dyskinesia, Pain
Adverse event was reported on Jul 29, 2010 by a Female patient taking Oxaliplatin (View Usage) (Dosage: 85 Mg/m2, Infused Over 2 Hours) was diagnosed with rectal cancer and. Location: UNITED STATES , 70 years of age, Patient had the following side effects: deafness neurosensory, deafness unilateral, dyskinesia, pain (What is pain?). During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CALCIUM (View Calcium Review and Calcium Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ).

6910387-3 | C-reactive Protein Increased, Cardiac Arrest, Dehydration, Diarrhoea, Febrile Neutropenia, Intestinal Obstruction, Mucous Stools, Sepsis
on Aug 02, 2010 Female patient from NETHERLANDS , 53 years of age, was treated with Oxaliplatin (View Usage). After Oxaliplatin was administered, patient had the following side effects: c-reactive protein increased, cardiac arrest (What is cardiac arrest?), dehydration, diarrhoea, febrile neutropenia, intestinal obstruction, mucous stools, sepsis (What is sepsis?). Oxaliplatin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), ZOFRAN (View Zofran Review and Zofran Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6910211-9 | Acute Respiratory Failure, Decreased Appetite, Dizziness, Nausea, Palmar-plantar Erythrodysaesthesia Syndrome, Pneumonia Aspiration
on Aug 03, 2010 Male patient from JAPAN , 78 years of age, was diagnosed with colon cancer and was treated with Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, decreased appetite, dizziness (What is dizziness?), nausea (What is nausea?), palmar-plantar erythrodysaesthesia syndrome, pneumonia aspiration. Oxaliplatin dosage: . During the same period patient was treated with XELODA (Tri-weekly) (View Xeloda Review and Xeloda Label ).

6908054-5 | Anaphylactic Shock, Cardio-respiratory Arrest, Pneumonia
Patient was taking Oxaliplatin (View Usage). Patient had the following side effects: anaphylactic shock, cardio-respiratory arrest, pneumonia (What is pneumonia?) on Jul 30, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, weighting 134.5 lb, was diagnosed with colon cancer and. Oxaliplatin dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6907685-6 | Full Blood Count Decreased, Infusion Related Reaction, Renal Disorder
Adverse event was reported on Jul 26, 2010 by a Female patient taking Oxaliplatin (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: UNITED STATES , 56 years of age, After Oxaliplatin was administered, patient had the following side effects: full blood count decreased, infusion related reaction, renal disorder. During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized.

6905259-4 | Fistula
on Jul 26, 2010 Male patient from BELGIUM , 64 years of age, was treated with Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: fistula (What is fistula?). Oxaliplatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

6905195-3 | Dyspnoea, Femoral Artery Embolism, Peripheral Ischaemia, Urosepsis
on Jul 24, 2010 Female patient from UNITED KINGDOM , 60 years of age, was treated with Oxaliplatin (View Usage). Patient had the following side effects: dyspnoea, femoral artery embolism, peripheral ischaemia, urosepsis. Oxaliplatin dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ADCAL (View Adcal Review and Adcal Label ). Patient was hospitalized.

6899783-0 | Respiratory Failure
Patient was taking Oxaliplatin (View Usage). After Oxaliplatin was administered, patient had the following side effects: respiratory failure on Jul 26, 2010 from JAPAN Additional patient health information: Male patient , 79 years of age, was diagnosed with colon cancer and. Oxaliplatin dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6899755-6 | Diarrhoea, Electrolyte Imbalance, Nephropathy Toxic
Adverse event was reported on Jul 27, 2010 by a Male patient taking Oxaliplatin (View Usage) (Dosage: ) was diagnosed with gastric cancer and. Location: NETHERLANDS , 75 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, electrolyte imbalance, nephropathy toxic. During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

6896817-4 | Acute Respiratory Distress Syndrome, Fungal Infection, Hypoxia, Interstitial Lung Disease, Metastases To Lung, Respiratory Failure, Sputum Culture Positive
on Jul 12, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 69 years of age, was diagnosed with colorectal cancer metastatic and was treated with Oxaliplatin (View Usage). Patient had the following side effects: acute respiratory distress syndrome, fungal infection (What is fungal infection?), hypoxia, interstitial lung disease, metastases to lung, respiratory failure, sputum culture positive. Oxaliplatin dosage: (85 Mg/m2, On Day 1, Every 2 Weeks). During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN (CALCIUM FOLINATE) (CALCIUM FOLINATE) (View Leucovorin (calcium Folinate) (calcium Folinate) Review and Leucovorin (calcium Folinate) (calcium Folinate) Label ), CETUXIMAB (CETUXIMAB) (CETUXIMAB) (View Cetuximab (cetuximab) (cetuximab) Review and Cetuximab (cetuximab) (cetuximab) Label ). Patient was hospitalized.

6895917-2 | Cholestatic Liver Injury, Diarrhoea, Renal Failure Acute
on Jul 23, 2010 Female patient from UNITED KINGDOM , 63 years of age, weighting 132.3 lb, was treated with Oxaliplatin (View Usage). After Oxaliplatin was administered, patient had the following side effects: cholestatic liver injury, diarrhoea, renal failure acute. Oxaliplatin dosage: Unk. During the same period patient was treated with CAPECITABINE (Unk) (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized and became disabled.

6888243-9 | Anaemia, Sepsis
Patient was taking Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, sepsis (What is sepsis?) on Jul 20, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 64 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?), thrombosis prophylaxis and. Oxaliplatin dosage: Unk. During the same period patient was treated with FLUOROURACIL (Unk) (View Fluorouracil Review and Fluorouracil Label ), ATORVASTATIN (10 Mg, Unk) (View Atorvastatin Review and Atorvastatin Label ), ANTITHROMBOTIC AGENTS (1 Df, Unk) (View Antithrombotic Agents Review and Antithrombotic Agents Label ), CINCHOCAINE HYDROCHLORIDE (Unk) (View Cinchocaine Hydrochloride Review and Cinchocaine Hydrochloride Label ), DOMPERIDONE (20 Mg, Tid) (View Domperidone Review and Domperidone Label ), FELODIPINE (Unk) (View Felodipine Review and Felodipine Label ). Patient was hospitalized.

6887905-7 | Cardiac Arrest, Ventricular Fibrillation
Adverse event was reported on Jul 28, 2010 by a Male patient taking Oxaliplatin (View Usage) (Dosage: ) . Location: SPAIN , 49 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), ventricular fibrillation. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

6887719-8 | Acute Coronary Syndrome, Ascites, Dehydration, Diarrhoea, Hepatic Failure, Renal Impairment, Respiratory Failure
on Jul 26, 2010 Female patient from UNITED KINGDOM , 63 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Oxaliplatin (View Usage). After Oxaliplatin was administered, patient had the following side effects: acute coronary syndrome, ascites, dehydration, diarrhoea, hepatic failure, renal impairment, respiratory failure. Oxaliplatin dosage: . During the same period patient was treated with CAPECITABINE (D1-14 Q21d) (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized.

6883975-0 | Dyspnoea Exertional, Phrenic Nerve Paralysis
on Jul 26, 2010 Male patient from GERMANY , 50 years of age, was treated with Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea exertional, phrenic nerve paralysis. Oxaliplatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), NEXIUM (View Nexium Review and Nexium Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), CLEXANE (View Clexane Review and Clexane Label ).

6883967-1 | Respiratory Failure
Patient was taking Oxaliplatin (View Usage). Patient had the following side effects: respiratory failure on Jul 26, 2010 from JAPAN Additional patient health information: Male patient , 79 years of age, . Oxaliplatin dosage: .

6883943-9 | Cholestatic Liver Injury, Diarrhoea, Renal Failure Acute
Adverse event was reported on Jul 23, 2010 by a Female patient taking Oxaliplatin (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 63 years of age, weighting 132.3 lb, After Oxaliplatin was administered, patient had the following side effects: cholestatic liver injury, diarrhoea, renal failure acute. During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized and became disabled.

6883467-9 | Intestinal Perforation
on Jul 26, 2010 Male patient from SPAIN , 62 years of age, was treated with Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal perforation. Oxaliplatin dosage: . During the same period patient was treated with CAPECITABINE (Given For 14 Days/cycle) (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized.

6882418-0 | Nephropathy Toxic, Renal Failure
on Jul 28, 2010 Male patient from UNITED STATES , weighting 244.1 lb, was diagnosed with malignant hepatobiliary neoplasm and was treated with Oxaliplatin (View Usage). Patient had the following side effects: nephropathy toxic, renal failure. Oxaliplatin dosage: Iv, 48 Mg/m^2 (107mg). During the same period patient was treated with SORAFENIB (200 Mg Po Qod) (View Sorafenib Review and Sorafenib Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized.

6880294-3 | Cholangitis
Patient was taking Oxaliplatin (View Usage). After Oxaliplatin was administered, patient had the following side effects: cholangitis on Jul 21, 2010 from ITALY Additional patient health information: Male patient , 58 years of age, weighting 147.7 lb, was diagnosed with adenocarcinoma pancreas, prophylaxis and. Oxaliplatin dosage: . During the same period patient was treated with GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), CLISMA FLEET (View Clisma Fleet Review and Clisma Fleet Label ). Patient was hospitalized.

6879916-2 | Hypophagia
Adverse event was reported on Jul 20, 2010 by a Male patient taking Oxaliplatin (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: NETHERLANDS , 81 years of age, Patient experienced the following unwanted or unexpected effects: hypophagia. During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

6879374-8 | Dyspnoea Exertional, Phrenic Nerve Paralysis
on Jul 22, 2010 Male patient from GERMANY , 50 years of age, was treated with Oxaliplatin (View Usage). Patient had the following side effects: dyspnoea exertional, phrenic nerve paralysis. Oxaliplatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), NEXIUM (View Nexium Review and Nexium Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), CLEXANE (View Clexane Review and Clexane Label ).

6879315-3 | Shock
on Jul 15, 2010 Male patient from JAPAN , 69 years of age, weighting 145.5 lb, was diagnosed with colon cancer and was treated with Oxaliplatin (View Usage). After Oxaliplatin was administered, patient had the following side effects: shock. Oxaliplatin dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ).

6877131-X | Urticaria
Patient was taking Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria on Jul 27, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 208.0 lb, was diagnosed with colon cancer and. Oxaliplatin dosage: 162 Mg Q 2 Weeks Iv Drip. During the same period patient was treated with FOLFOX (View Folfox Review and Folfox Label ), ONDANSETRON 32 MG (View Ondansetron 32 Mg Review and Ondansetron 32 Mg Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6870143-1 | Bronchospasm, Chest Discomfort, Dysphagia, Flushing, Tachycardia
Adverse event was reported on Jul 06, 2010 by a Male patient taking Oxaliplatin (View Usage) (Dosage: 120 Mg Milligram(s), Intravenous) was diagnosed with neoplasm malignant and. Location: UNITED KINGDOM , 47 years of age, Patient had the following side effects: bronchospasm, chest discomfort, dysphagia, flushing, tachycardia. During the same period patient was treated with (DEXAMETHASONE) (View (dexamethasone) Review and (dexamethasone) Label ), (FLUOROURACIL) (View (fluorouracil) Review and (fluorouracil) Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), (PIRITON) (View (piriton) Review and (piriton) Label ).

6867280-4 | Proteinuria
on Jul 13, 2010 Female patient from UNITED STATES , 61 years of age, was diagnosed with colon cancer and was treated with Oxaliplatin (View Usage). After Oxaliplatin was administered, patient had the following side effects: proteinuria. Oxaliplatin dosage: . During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

6866127-X | Pneumonia, Pulmonary Embolism, Pulmonary Hypertension
on Jul 13, 2010 Male patient from KOREA, REPUBLIC OF , 31 years of age, was diagnosed with metastatic gastric cancer and was treated with Oxaliplatin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?), pulmonary hypertension (What is pulmonary hypertension?). Oxaliplatin dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6865951-7 | Diarrhoea, Dihydropyrimidine Dehydrogenase Deficiency, Mucosal Inflammation, Neutropenia, Performance Status Decreased, Perineal Ulceration, Pharyngeal Ulceration, Thrombocytopenia
Patient was taking Oxaliplatin (View Usage). Patient had the following side effects: diarrhoea, dihydropyrimidine dehydrogenase deficiency, mucosal inflammation, neutropenia, performance status decreased, perineal ulceration, pharyngeal ulceration, thrombocytopenia on Jul 01, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 64 years of age, weighting 167.6 lb, was diagnosed with colorectal cancer metastatic and. Oxaliplatin dosage: Once Every 3 Weeks Intravenous. During the same period patient was treated with CAPECITABINE (Twice A Day, Oral) (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized.